Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valganciclovir in CFS with Elevated HHV-6 and EBV Titers
NCT00478465Phase 2Completed
- Sponsor
- Stanford University
- Start
- May 2007
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valganciclovir in myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS), sponsored by Stanford University. Started May 2007; status: completed.
02
Drugs
valganciclovir
03
Conditions
myalgic encephalomyelitis chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT00478465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478465.